Niacin is a form of vitamin B3 that you get from food and supplements. NAD+ (nicotinamide adenine dinucleotide) is a molecule your cells build from niacin and use to run hundreds of essential chemical reactions. Think of niacin as one of the raw materials and NAD+ as the finished product your body actually puts to work. The relationship between them is more layered than a simple “before and after,” though, because niacin is not the only ingredient cells can use to make NAD+, and NAD+ does far more than most people realize.
Niacin Is the Nutrient, NAD+ Is the Workhorse
Niacin refers to two closely related compounds: nicotinic acid and nicotinamide. Both are classified as vitamin B3. You find them in meat, fish, legumes, and fortified grains. When your body absorbs niacin, cells convert it through a series of enzymatic steps into NAD+, the molecule that actually participates in metabolism. NAD+ acts as a cofactor in energy-producing reactions like the breakdown of glucose and the production of ATP in mitochondria, and it also plays roles in DNA repair and gene regulation.1PubMed Central. Niacin: an old lipid drug in a new NAD+ dress Without enough NAD+, those processes slow down or stall entirely.
The relationship is roughly analogous to iron ore versus a steel beam. You need the raw material, but it is the finished form that holds up the building. Niacin on its own does not power your cells. It has to be converted first. And just as there is more than one way to produce steel, there is more than one precursor your body can use to make NAD+.
How Your Body Turns Niacin Into NAD+
Your cells have multiple routes to synthesize NAD+, and which one they use depends partly on what raw material is available. The classic route for nicotinic acid (the form most people mean when they say “niacin”) is called the Preiss-Handler pathway. In that process, nicotinic acid is converted to nicotinic acid mononucleotide, then to nicotinic acid adenine dinucleotide, and finally to NAD+. This pathway has been understood since the 1950s and remains one of the best-characterized routes to NAD+ production.
Your body can also make NAD+ from scratch using the amino acid tryptophan, through what is called the de novo synthesis pathway. Tryptophan gets converted to a compound called quinolinate, which then feeds into the same downstream steps that nicotinic acid uses.1PubMed Central. Niacin: an old lipid drug in a new NAD+ dress This route is less efficient than the Preiss-Handler pathway, but it serves as a backup when dietary niacin is scarce.
There is a third major route, the salvage pathway, which recycles nicotinamide, a byproduct of NAD+ consumption. When enzymes use NAD+ to do their jobs, they often break it apart and release nicotinamide. Rather than letting that go to waste, cells recapture it using an enzyme called NAMPT, converting it back through nicotinamide mononucleotide and ultimately back to NAD+.2PubMed Central. Mechanisms of the NAD+ salvage pathway in enhancing skeletal muscle function In most tissues, this salvage pathway is actually the dominant source of day-to-day NAD+ supply, not the dietary route. Your cells are constantly breaking down and rebuilding NAD+ in a rapid cycle.
NAD+ Precursors Beyond Niacin
One source of confusion in the supplement market is that niacin is not the only NAD+ precursor you can take. Two others have attracted significant research attention: nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). Both feed into NAD+ synthesis through different entry points.
Nicotinamide riboside was identified as a previously unrecognized NAD+ precursor in a landmark study that showed it can bypass the traditional Preiss-Handler pathway entirely.3PubMed. Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans NR enters cells through specific transporters and gets phosphorylated into NMN by NR kinase enzymes, then converted to NAD+.4PubMed Central. Equilibrative Nucleoside Transporters Mediate the Import of Nicotinamide Riboside and Nicotinic Acid Riboside into Human Cells NMN, meanwhile, can also be taken directly as a supplement, and research has identified a specific transporter (Slc12a8) that moves NMN into cells in a sodium-dependent manner.5PubMed Central. Slc12a8 is a nicotinamide mononucleotide transporter
All of these precursors end up at the same destination: NAD+. The practical differences come down to side effects, dosing, and how efficiently each one raises NAD+ levels in specific tissues. Nicotinic acid, the classic niacin, is cheap and well-studied but comes with a notorious flushing side effect. NR and NMN are newer, more expensive, and generally do not cause flushing, though human evidence for long-term benefits remains limited compared to what we know about niacin.
What NAD+ Actually Does Once It Exists
NAD+ is not a passive bystander waiting to be called upon. It is one of the most active molecules in your body, participating in over 500 enzymatic reactions. Its two biggest roles are energy production and cellular signaling.
For energy, NAD+ acts as an electron shuttle. During the breakdown of food molecules, NAD+ picks up electrons and becomes NADH, its reduced form. That NADH then delivers those electrons to the mitochondria, where they drive the production of ATP. Maintaining the right balance between NAD+ and NADH is essential for mitochondrial function.6PubMed Central. The dynamic regulation of NAD metabolism in mitochondria When that ratio gets disrupted, cells struggle to generate the energy they need.
Beyond energy, NAD+ gets consumed (not just borrowed) by enzymes involved in DNA repair and gene regulation. PARP1, one of the most important DNA damage sensors, uses NAD+ to flag and repair breaks in DNA. When DNA damage is severe, PARP1 can burn through NAD+ rapidly, causing levels to plummet and triggering a metabolic shift across the entire cell.7PubMed Central. NAD+ consumption by PARP1 in response to DNA damage triggers metabolic shift critical for damaged cell survival PARP1 is the single largest consumer of NAD+ in the nucleus, and its appetite for the molecule links DNA integrity directly to overall cell metabolism.8PubMed Central. The taming of PARP1 and its impact on NAD(+) metabolism
Another family of NAD+-consuming enzymes, the sirtuins, use NAD+ to remove chemical tags from proteins and histones, influencing everything from inflammation to fat storage. SIRT1, the most studied member of this family, deacetylates transcription factors like p53 and FOXO proteins, linking NAD+ availability to stress responses and potentially to lifespan.9PubMed. Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1 The salvage pathway enzymes NAMPT and NMNAT-1 work directly at gene promoters to regulate SIRT1 activity, meaning that local NAD+ production fine-tunes which genes get turned on or off.10Journal of Biological Chemistry. Enzymes in the NAD+ Salvage Pathway Regulate SIRT1 Activity at Target Gene Promoters
The Niacin Flush and Why NAD+ Precursors Don’t All Cause It
If you have ever taken a niacin supplement and experienced an intense, prickly warmth spreading across your face and chest, you have met the niacin flush. It is harmless but deeply unpleasant, and it is specific to nicotinic acid. The mechanism involves immune cells in the skin called Langerhans cells, which carry a receptor called GPR109A. When nicotinic acid binds that receptor, the Langerhans cells release prostaglandins, particularly prostaglandin D2, which dilates blood vessels in the skin and produces the characteristic redness and heat.11PubMed Central. The mechanism and mitigation of niacin-induced flushing12PubMed. Langerhans cells release prostaglandin D2 in response to nicotinic acid
The reason nicotinamide, NR, and NMN do not trigger the same reaction is that they do not activate GPR109A. The flush is a pharmacological effect of the nicotinic acid form of niacin interacting with a specific receptor, not a downstream consequence of raising NAD+ levels. So while all these precursors feed into NAD+ production, only nicotinic acid comes with the flushing baggage. Extended-release niacin formulations reduce the intensity of flushing by slowing absorption, but they do not eliminate it entirely.
NAD+ and Aging
One of the most active areas of NAD+ research concerns what happens to its levels as you get older. Multiple lines of evidence suggest that NAD+ declines with age, though the precise magnitude and drivers of that decline remain debated. Potential explanations include increased consumption of NAD+ by DNA repair enzymes responding to accumulated damage, decreased activity of salvage pathway enzymes like NAMPT, and shifts in the types and proportions of cells in aging tissues.13PubMed Central. Age-related NAD+ decline
This age-related decline has prompted interest in whether supplementing NAD+ precursors could slow aspects of aging. Animal studies have been encouraging: boosting NAD+ in aged mice improves mitochondrial function, insulin sensitivity, and physical endurance. Human trials, however, are still relatively early-stage. Methods for measuring NAD+ in living people have only recently become practical, with newer assays able to quantify whole blood NAD+ from just a few microliters of capillary blood.14PubMed Central. Fingerstick blood assay maps real‐world NAD+ disparity across gender and age That kind of accessible testing is a prerequisite for large-scale clinical studies, and those studies are still underway.
Niacin’s Rise and Fall as a Heart Drug
For decades, niacin was one of the few tools doctors had for raising HDL cholesterol (the “good” kind) and lowering triglycerides. It was prescribed at pharmacological doses far above what you would get from food. But the story has not aged well. A major meta-analysis found no overall preventive association between niacin and cardiovascular outcomes when used alongside modern statin therapy. The only cardiovascular benefits that emerged were from niacin monotherapy in patients not taking statins, and those results came mainly from trials conducted in the 1970s and 1980s, before statins existed.15PubMed Central. Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes
The most influential modern trial, AIM-HIGH, tested whether adding extended-release niacin to intensive statin therapy would reduce heart attacks and strokes. It was stopped early after about three years because niacin showed no benefit whatsoever. Niacin did improve the lipid numbers on paper, raising HDL and lowering LDL and triglycerides, but those improved numbers did not translate into fewer heart events. The rate of the primary endpoint was essentially identical between the niacin and placebo groups.16PubMed. Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy That finding was a sobering reminder that changing a biomarker is not the same as preventing disease. Niacin is still occasionally prescribed for specific lipid abnormalities, but it has largely been sidelined as a cardiovascular treatment.
NAD+ in the Immune System
A less well-known dimension of NAD+ biology is its role in immune cell function. Macrophages, the immune cells that engulf pathogens and coordinate inflammatory responses, depend heavily on NAD+ to balance their metabolic programs. When macrophages are activated by infection signals, they shift from aerobic energy production to a faster, less efficient mode. This shift requires careful management of NAD+ levels. Depleting NAD+ in macrophages pushes them toward a more inflammatory state, with increased production of inflammatory signaling molecules.17PubMed Central. NAD+ metabolism and function in innate and adaptive immune cells
Restoring NAD+ has the opposite effect. In aging macrophages, where de novo NAD+ synthesis is impaired, experimentally boosting NAD+ generation restored oxidative metabolism and more balanced immune responses.18PubMed Central. Macrophage de novo NAD+ synthesis specifies immune function in aging and inflammation In a mouse model of colitis, enhancing NAD+ levels in macrophages through a compound that modulates NQO1 increased anti-inflammatory markers like IL-10 while reducing pro-inflammatory ones like TNF-α, and the effect was linked to activation of several sirtuins.19PubMed. NAD(+) modulation of intestinal macrophages renders anti-inflammatory functionality and ameliorates gut inflammation The picture that is emerging is that NAD+ depletion can tip immune cells toward excessive inflammation, while restoring it may help recalibrate the response.
NAD+ and Nerve Health
Perhaps the most surprising area of NAD+ research involves nerves. When an axon (the long projection of a nerve cell) is injured, it does not just passively wither. It activates a self-destruction program called Wallerian degeneration. This process turns out to be intimately linked to NAD+ metabolism. A protein called SARM1, which acts as an NAD+-degrading enzyme, is a central executioner of this program. When axonal NAD+ levels drop below a threshold, SARM1 activates and rapidly destroys the remaining NAD+, triggering irreversible axon breakdown.20PubMed Central. NAD+-dependent mechanism of pathological axon degeneration
This discovery reframed neurodegeneration as intrinsically linked to NAD+ and energy metabolism.21PubMed Central. NAD(+), Axonal Maintenance, and Neurological Disease And it opened a therapeutic angle: if you can keep axonal NAD+ levels high enough, you might delay or prevent degeneration. In mice, supplementing NAD+ with nicotinamide riboside slowed axon degeneration and demyelination after nerve injury, and genetic deletion of CD38 (an enzyme that consumes NAD+) had a similar protective effect.22PubMed Central. Deletion of CD38 and supplementation of NAD(+) attenuate axon degeneration in a mouse facial nerve axotomy model Whether this translates to human neurodegenerative diseases is still an open question, but it underscores that NAD+ is not just about energy. It is a survival signal for vulnerable cell structures.
NAD+ Runs on a Clock
Your cells do not maintain a flat, steady level of NAD+ around the clock. NAD+ concentrations oscillate over a 24-hour cycle, and this rhythm is driven by the same molecular clock that governs your sleep-wake cycle. The key link is NAMPT, the rate-limiting enzyme in the salvage pathway. NAMPT expression rises and falls rhythmically under the control of core clock proteins CLOCK and BMAL1, and the resulting oscillation in NAD+ feeds back into the clock itself by regulating SIRT1 activity at clock-gene promoters.23PubMed Central. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis
SIRT1’s deacetylase activity follows these NAD+ oscillations, correlating with rhythmic changes in histone acetylation at circadian gene promoters.24PubMed Central. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control Recent work has shown that this NAMPT-NAD+ feedback loop does not operate identically in every tissue, suggesting that different organs may have distinct circadian metabolic profiles driven by local NAD+ dynamics.25PubMed Central. NAMPT-dependent NAD(+) biosynthesis controls circadian metabolism in a tissue-specific manner This connection between NAD+ and circadian biology is one reason researchers suspect that disrupted sleep patterns may contribute to metabolic dysfunction beyond simple fatigue: if your clock is off, your NAD+ rhythm may be off too.
The Pellagra Connection and Why Niacin Fortification Still Matters
The most dramatic demonstration of what happens when niacin-to-NAD+ conversion fails at a population level was pellagra, a disease that killed thousands of people in the early twentieth century. Pellagra causes dermatitis, diarrhea, dementia, and eventually death, all from a severe lack of niacin in the diet. It was epidemic in communities relying heavily on corn, which contains niacin in a chemically bound form that the body cannot easily absorb. The addition of niacin to enriched flour and bread in the 1930s and 1940s effectively eliminated pellagra in the United States.26PubMed Central. Effectiveness of food fortification in the United States: the case of pellagra
Today, outright pellagra is rare in countries with grain fortification programs, but subclinical niacin insufficiency may be more common than appreciated, particularly among people with alcohol use disorder, certain malabsorption conditions, or very restricted diets. Because NAD+ sits at the center of so many metabolic processes, even a modest shortfall in niacin intake could have consequences that do not look anything like classic pellagra but still reflect inadequate NAD+ synthesis.
When Niacin Intake Tips From Helpful to Harmful
A recent analysis of dietary niacin intake in a large U.S. population sample found a U-shaped relationship with metabolic liver disease. The odds of disease decreased as niacin intake rose until reaching a threshold of about 24 milligrams per day, after which the odds began climbing again.27PubMed Central. Association of niacin intake and metabolic dysfunction-associated steatotic liver disease: findings from National Health and Nutrition Examination Survey That sweet spot is close to the recommended daily allowance for adults, which sits around 14 to 16 milligrams depending on sex. Taking high-dose niacin supplements without medical supervision could push intake well beyond that threshold. The flushing side effect tends to get most of the attention, but the emerging data on liver risk at high intakes is a more serious consideration for people self-dosing in pursuit of NAD+ boosting.
This is a useful distinction to keep in mind when comparing niacin with newer NAD+ precursors like NR and NMN. Those alternatives have different safety profiles, partly because they do not activate GPR109A and partly because they enter NAD+ synthesis at different metabolic steps. But “different” does not automatically mean “safer at high doses.” Long-term safety data for NR and NMN at supplemental doses remains limited, and the assumption that more NAD+ is always better has not been validated in humans.